Table 2.
Median values of uFABP3/uCr in PAD and non-PAD patients with and without various PAD risk factors and comorbidities.
| Condition | Non-PAD¶ | PAD¶ | ||||
|---|---|---|---|---|---|---|
| Condition absent | Condition present | p-value† | Condition absent | Condition present | p-value‡ | |
| Age ≥ 65 | 2.44 (1.76–3.33) | 2.60 (2.33–2.93) | 0.820 | 3.69 (3.11–8.64) | 4.77 (2.62–8.08) | 0.915 |
| Sex-male | 2.46 (1.82–3.16) | 2.49 (1.72–3.17) | 0.989 | 5.70 (3.43–8.94) | 3.63 (2.50–7.89) | 0.159 |
| Hypertension | 2.24 (1.64–2.83) | 2.70 (2.28–3.67) | 0.067 | 3.90 (2.80–6.77) | 4.45 (2.76–8.78) | 0.383 |
| Hypercholesteremia | 2.45 (1.78–3.30) | 2.53 (1.78–2.95) | 0.837 | 5.81 (3.36–7.31) | 3.90 (2.62–8.13) | 0.437 |
| Diabetes | 2.45 (1.77–3.21) | 2.65 (2.14–3.43) | 0.513 | 3.81 (2.85–6.85) | 5.87 (2.74–8.13) | 0.609 |
| Smoking | 2.43 (1.72–3.66) | 2.50 (1.80–3.04) | 0.893 | 4.77 (3.13–9.08) | 4.07 (2.76–8.08) | 0.391 |
| History of CAD | 2.49 (1.77–3.23) | 2.45 (1.80–3.04) | 0.899 | 3.90 (2.90–8.54) | 4.28 (2.48–7.32) | 0.571 |
¶Median uFABP3/uCr, μg/g (interquartile range) for each subgroup.
†Difference among non-PAD patients.
‡Difference among PAD patients.